Indian online pharmacy and telemedicine startup PharmEasy, on Tuesday, announced its merger with competitor Medlife starting 25 May, 2021. Both companies’ plans of a merger first came to light in August last year, when PharmEasy had submitted a proposal to the Competition Commission of India (CCI) for acquiring Medlife.
The deal saw API Holdings, the parent entity of PharmEasy, acquire 100% equity shares of Medlife. Medlife’s promoters have in return got a 19.95% stake in the merged entity, which is expected to be valued at $1 Bn.
PharmEasy cofounder Dhaval Shah wrote on LinkedIn that the merged entity will be